The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Intramyocardial Transplantation of Autologous CD34 + Stem Cells for Intractable Angina: A Phase I/IIa Double-Blind, Randomized Controlled Trial
Open accessAbstract
Background— A growing population of patients with coronary artery disease experiences angina that is not amenable to revascularization and is refractory to medical therapy. Preclinical studies have indicated that human CD34 + stem cells induce neovascularization in ischemic myocardium, which enhances perfusion and function. Methods and Results— Twenty-four patients (19 men and 5 women aged 48 to 84 years) with Canadian Cardiovascular Society class 3 or 4 angina who were undergoing optimal medical treatment and who were not candidates for mechanical revascularization were enrolled in a double-blind, randomized (3:1), placebo-controlled dose-escalating study. Patients received granulocyte colony-stimulating factor 5 μg · kg −1 · d −1 for 5 days with leukapheresis on the fifth day. Selection of CD34 + cells was performed with a Food and Drug Administration–approved device. Electromechanical mapping was performed to identify ischemic but viable regions of myocardium for injection of cells (versus saline). The total dose of cells was distributed in 10 intramyocardial, transendocardial injections. Patients were required to have an implantable cardioverter-defibrillator or to temporarily wear a LifeVest wearable defibrillator. No incidence was observed of myocardial infarction induced by mobilization or intramyocardial injection. The intramyocardial injection of cells or saline did not result in cardiac enzyme elevation, perforation, or pericardial effusion. No incidence of ventricular tachycardia or ventricular fibrillation occurred during the administration of granulocyte colony-stimulating factor or intramyocardial injections. One patient with a history of sudden cardiac death/ventricular tachycardia/ventricular fibrillation had catheter-induced ventricular tachycardia during mapping that required cardioversion. Serious adverse events were evenly distributed. Efficacy parameters including angina frequency, nitroglycerine usage, exercise time, and Canadian Cardiovascular Society class showed trends that favored CD34 + cell–treated patients versus control subjects given placebo. Conclusions— A randomized trial of intramyocardial injection of autologous CD34 + cells in patients with intractable angina was completed that provides evidence for feasibility, safety, and bioactivity. A larger phase IIb study is currently under way to further evaluate this therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
Self-citationKocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., Homma, S., Edwards, N. M., & Itescu, S. (2001) · Nature Medicine · doi:10.1038/86498 · Cited by 2,540
Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C., Martin, H., Zeiher, A. M., & Dimmeler, S. (2001) · Circulation Research · doi:10.1161/hh1301.093953 · Cited by 2,329
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
Schächinger, V., Erbs, S., Elsässer, A., Haberbosch, W., Hambrecht, R., Hölschermann, H., Yu, J., Corti, R., Mathey, D. G., Hamm, C. W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060186 · Cited by 1,890
Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia
Kawamoto, A., Gwon, H.-C., Iwaguro, H., Yamaguchi, J.-I., Uchida, S., Masuda, H., Silver, M., Ma, H., Kearney, M., Isner, J. M., et al. (2001) · Circulation · doi:10.1161/01.cir.103.5.634 · Cited by 1,220
Self-citationTranscoronary Transplantation of Progenitor Cells after Myocardial Infarction
Assmus, B., Honold, J., Schächinger, V., Britten, M. B., Fischer-Rasokat, U., Lehmann, R., Teupe, C., Pistorius, K., Martin, H., Abolmaali, N. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051779 · Cited by 1,040
Parisi, A. F., Folland, E. D., & Hartigan, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201023260102 · Cited by 736
Kawamoto, A., Tkebuchava, T., Yamaguchi, J.-I., Nishimura, H., Yoon, Y.-S., Milliken, C., Uchida, S., Masuo, O., Iwaguro, H., Ma, H., et al. (2003) · Circulation · doi:10.1161/01.cir.0000046450.89986.50 · Cited by 650
Self-citationHeeschen, C., Lehmann, R., Honold, J., Assmus, B., Aicher, A., Walter, D. H., Martin, H., Zeiher, A. M., & Dimmeler, S. (2004) · Circulation · doi:10.1161/01.cir.0000124476.32871.e3 · Cited by 618
Ambrosio, G., Weisman, H. F., Mannisi, J. A., & Becker, L. C. (1989) · Circulation · doi:10.1161/01.cir.80.6.1846 · Cited by 468
Cited by
Stem-cell therapy for cardiac disease
Segers, V. F. M., & Lee, R. T. (2008) · Nature · doi:10.1038/nature06800 · Cited by 1,179
Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina
Losordo, D. W., Henry, T. D., Davidson, C., Sup Lee, J., Costa, M. A., Bass, T., Mendelsohn, F., Fortuin, F. D., Pepine, C. J., Traverse, J. H., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.245993 · Cited by 482
Self-citationLi, T.-S., Cheng, K., Malliaras, K., Smith, R. R., Zhang, Y., Sun, B., Matsushita, N., Blusztajn, A., Terrovitis, J., Kusuoka, H., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.029 · Cited by 461
Perin, E. C., Willerson, J. T., Pepine, C. J., Henry, T. D., Ellis, S. G., Zhao, D. X. M., Silva, G. V., Lai, D., Thomas, J. D., Kronenberg, M. W., et al. (2012) · JAMA · doi:10.1001/jama.2012.418 · Cited by 460
Self-citationStem cell treatment for acute myocardial infarction
Fisher, S. A., Zhang, H., Doree, C., Mathur, A., & Martin-Rendon, E. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006536.pub4 · Cited by 445
Concise Review: Circulating Endothelial Progenitor Cells for Vascular Medicine
Asahara, T., Kawamoto, A., & Masuda, H. (2011) · Stem Cells · doi:10.1002/stem.745 · Cited by 411
Self-citationEmbryonic Stem Cells Proliferate and Differentiate when Seeded into Kidney Scaffolds
Ross, E. A., Williams, M. J., Hamazaki, T., Terada, N., Clapp, W. L., Adin, C., Ellison, G. W., Jorgensen, M., & Batich, C. D. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111196 · Cited by 382
Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases
Burt, R. K. (2008) · JAMA · doi:10.1001/jama.299.8.925 · Cited by 354
Chronic Coronary Artery Disease: Diagnosis and Management
Cassar, A., Holmes, D. R., Rihal, C. S., & Gersh, B. J. (2009) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0391 · Cited by 324
Cell-Based Therapy of Myocardial Infarction
Dimmeler, S., Burchfield, J., & Zeiher, A. M. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.155317 · Cited by 302
van Ramshorst, J., Bax, J. J., Beeres, S. L. M. A., Dibbets-Schneider, P., Roes, S. D., Stokkel, M. P. M., de Roos, A., Fibbe, W. E., Zwaginga, J. J., Boersma, E., et al. (2009) · JAMA · doi:10.1001/jama.2009.685 · Cited by 300
Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review
Nguyen, P. K., Rhee, J.-W., & Wu, J. C. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2225 · Cited by 299
Cell therapy for cardiac repair—lessons from clinical trials
Behfar, A., Crespo-Diaz, R., Terzic, A., & Gersh, B. J. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.9 · Cited by 292
Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial
Perin, E. C., Sanz-Ruiz, R., Sánchez, P. L., Lasso, J., Pérez-Cano, R., Alonso-Farto, J. C., Pérez-David, E., Fernández-Santos, M. E., Serruys, P. W., Duckers, H. J., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.03.022 · Cited by 283
Li, T.-S., Cheng, K., Lee, S.-T., Matsushita, S., Davis, D., Malliaras, K., Zhang, Y., Matsushita, N., Smith, R. R., & Marbán, E. (2010) · Stem Cells · doi:10.1002/stem.532 · Cited by 263
Endothelial progenitor cells in neovascularization of infarcted myocardium
Jujo, K., Ii, M., & Losordo, D. W. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.08.003 · Cited by 262
Self-citationPostischemic Revascularization: From Cellular and Molecular Mechanisms to Clinical Applications
Silvestre, J.-S., Smadja, D. M., & Lévy, B. I. (2013) · Physiological Reviews · doi:10.1152/physrev.00006.2013 · Cited by 255
Stem cell therapy for chronic ischaemic heart disease and congestive heart failure
Fisher, S. A., Doree, C., Mathur, A., Taggart, D. P., & Martin-Rendon, E. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007888.pub3 · Cited by 254
Economic Impact of Angina After an Acute Coronary Syndrome: Insights From the MERLIN-TIMI 36 Trial
Arnold, S. V., Morrow, D. A., Lei, Y., Cohen, D. J., Mahoney, E. M., Braunwald, E., & Chan, P. S. (2009) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.829523 · Cited by 128
Metadata
- Authors
- Losordo, D. W., Schatz, R. A., White, C. J., Udelson, J. E., Veereshwarayya, V., Durgin, M., Poh, K. K., Weinstein, R., Kearney, M., Chaudhry, M., Burg, A., Eaton, L., Heyd, L., Thorne, T., Shturman, L., Hoffmeister, P., Story, K., Zak, V., Dowling, D., Traverse, J. H., Olson, R. E., Flanagan, J., Sodano, D., Murayama, T., Kawamoto, A., Kusano, K. F., Wollins, J., Welt, F., Shah, P., Soukas, P., Asahara, T., & Henry, T. D.
- Venue
- Circulation
- Published
- 2007-06-26
- Volume
- 115
- Issue
- 25
- Pages
- 3165-3172
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2046253273
- Cited by
- 557
- References
- 26
- FWCI
- 23.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.